Effect of Yishenhuoxue Capsule on CD40 and MMP-9 Expression in ApoE-knockout Mice

Liu Guilin,Zhang Jidong,Dai Wei
DOI: https://doi.org/10.3969/j.issn.1672-1349.2009.09.020
2009-01-01
Abstract:Objective To investigate the effect of Yishenhuoxue capsule on the expression of immune inflammatory factors in atherosclerotic mice. Methods Apolipoprotein E-knockout (apoE-KO) mice were fed with high fat diet. At 20 weeks of age,mice were divided into three groups:Model group given 0.2 mL normal sodium daily,Yishenhuoxue capsule low dose group (low dose group) and Yishenhuoxue capsule high dose group (high dose group). Yishenhuoxue capsule were orally administered daily at 500 mg/kg and 2 500 mg/kg respectively in low dose and high dose group.After administered for 12 weeks,mice were sacrificed. Serum oxidized low density lipoprotein(oxLDL) were examined by ELISA. The expression of cell differentiation antigen 40 (CD40) and matrix metalloproteinase9 (MMP9) in aortas were examined by immunohistochemistry and real-time RT-PCR.Results The levels of serum oxLDL in Yishenhuoxue capsule groups were lower than that in model group(P<0.01 or P<0.001). The expression of CD40 and MMP9 of aortas were decreased in Yishenhuoxue capsule groups. The levels in high dose group were lower than that in low dose group(P<0.05). Conclusion Yishenhuoxue capsule could prevent atherosclerosis by lowering serum oxLDL,down-regulating the expression of CD40 and MMP-9 in atherosclerotic mice.
What problem does this paper attempt to address?